- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Pixels ease amputees' pain
A new virtual reality system that gives the illusion that a person's amputated limb is still there has helped ease phantom pain in amputees.
A new virtual reality system that gives the illusion that a person's amputated limb is still there has helped ease phantom pain in amputees.
Previous research using a mirror-box had found that when a person's brain is tricked into believing it can see and move a phantom limb, pain can decrease. Rather than use mirrors, Craig D. Murray, Ph.D., and colleagues at the University of Manchester in the U.K. used the latest 3D computer-generated graphics to allow patients to see themselves with two sets of limbs. Patients can use their remaining physical arm or leg to control the movements of a computer-generated limb.
"One patient felt that the fingers of her amputated hand were continually clenched into her palm, which was very painful for her. However, after just one session using the virtual system, she began to feel movement in her fingers, and the pain began to ease," said Murray, who presented the study in Denmark at the 2006 Conference on Disability, Virtual Reality, and Associated Technologies.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
